Trials / Sponsors / Chengdu CoenBiotech Co., Ltd
Chengdu CoenBiotech Co., Ltd
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infe Tuberculosis | Phase 3 | 2025-08-09 |
| Recruiting | Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoper Non-Muscle Invasive Bladder Cancer | Phase 3 | 2023-12-28 |
| Unknown | Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Pre Tuberculosis | Phase 2 | 2023-07-18 |
| Completed | Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) i Tuberculosis | Phase 1 | 2023-01-17 |
| Completed | Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Non-muscular Invasive Bladder Cancer | Phase 1 | 2022-11-11 |